Literature DB >> 22644719

Dabigatran and left atrial appendage thrombus.

Alejandro Vidal1, Gabriel Vanerio.   

Abstract

A 59-year-old white woman with previous history of arterial hypertension consulted because of palpitations. Atrial fibrillation of uncertain duration was diagnosed. She was not receiving anticoagulants. A trans-esophageal echocardiogram was performed, and a large left atrial appendage thrombus was detected. A strategy of rate control and anti-vitamin K treatment was started. On the subsequent days, we could not reach therapeutic INRs. Therefore, it was decided to stop warfarin and initiate dabigatran. We describe the evolution of the patient, the thrombus resolution, and a successful electrical cardioversion. In our comments, we summarize the natural history of left atrial thrombus, both with and without anticoagulant therapy. We also discuss the differences between warfarin and dabigatran.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22644719     DOI: 10.1007/s11239-012-0747-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  20 in total

Review 1.  Prevention of cardioembolic stroke.

Authors:  William David Freeman; Maria I Aguilar
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 2.  The regulation of hemostasis: the protein C system.

Authors:  L H Clouse; P C Comp
Journal:  N Engl J Med       Date:  1986-05-15       Impact factor: 91.245

3.  Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.

Authors:  Z Xiao; P Théroux
Journal:  Circulation       Date:  1998-01-27       Impact factor: 29.690

4.  Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study).

Authors:  Senthil K Thambidorai; R Daniel Murray; Kapil Parakh; Tushar K Shah; Ian W Black; Susan E Jasper; Jianbo Li; Carolyn Apperson-Hansen; Craig R Asher; Richard A Grimm; Allan L Klein
Journal:  Am J Cardiol       Date:  2005-10-01       Impact factor: 2.778

Review 5.  Inhibitor binding to thrombin: x-ray crystallographic studies.

Authors:  D W Banner; P Hadváry
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

6.  Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS.

Authors:  Peter R Sinnaeve; Yao Huang; Kris Bogaerts; Alec Vahanian; Jennifer Adgey; Paul W Armstrong; Lars Wallentin; Frans J Van de Werf; Christopher B Granger
Journal:  Am Heart J       Date:  2006-10       Impact factor: 4.749

7.  Thrombi of different pathologies: implications for diagnosis and treatment.

Authors:  Carlos G Santos-Gallego; Jeremías Bayón; Juan José Badimón
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-06

Review 8.  Update on pharmacologic approaches to prevent thromboembolism in atrial fibrillation: are thrombin and factor Xa inhibitors the ultimate answer?

Authors:  Oliver Wolfram; Matthias Hammwoehner; Felix Gramley; Andreas Goette
Journal:  Curr Vasc Pharmacol       Date:  2011-05       Impact factor: 2.719

Review 9.  Stroke risk and antithrombotic strategies in atrial fibrillation.

Authors:  Caroline Medi; Graeme J Hankey; Saul B Freedman
Journal:  Stroke       Date:  2010-10-07       Impact factor: 7.914

10.  Left ventricular mural thrombi complicating acute myocardial infarction. Long-term follow-up with serial echocardiography.

Authors:  D J Weinreich; J F Burke; F J Pauletto
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

View more
  26 in total

1.  Two-week administration of rivaroxaban resolved left atrial thrombus.

Authors:  Toru Kato; Masahiro Yasaka; Taku Yabuki; Taichi Adachi; Shigeru Toyoda; Teruo Inoue
Journal:  J Cardiol Cases       Date:  2014-09-26

2.  Rationale and design of the RE-LATED AF--AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus--Effects of Dabigatran in patients with Atrial Fibrillation.

Authors:  Marion Ferner; Daniel Wachtlin; Torsten Konrad; Oliver Deuster; Thomas Meinertz; Stephan von Bardeleben; Thomas Münzel; Monika Seibert-Grafe; Günter Breithardt; Thomas Rostock
Journal:  Clin Res Cardiol       Date:  2015-06-25       Impact factor: 5.460

Review 3.  Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis.

Authors:  Eiman Ghaffarpasand; Maneli D Tehrani; Jolanta Marszalek; Gerald Chi
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

4.  Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab.

Authors:  Chee Hoou Loh; Geoffrey Herkes
Journal:  BMJ Case Rep       Date:  2019-05-05

5.  Left atrial thrombus despite continuous direct oral anticoagulant or warfarin therapy in patients with atrial fibrillation: insights into rates and timing of thrombus resolution.

Authors:  Michael S Wu; James Gabriels; Mohammad Khan; Nada Shaban; Salvatore A D'Amato; Christopher F Liu; Steven M Markowitz; James E Ip; George Thomas; Parmanand Singh; Bruce B Lerman; Apoor Patel; Jim W Cheung
Journal:  J Interv Card Electrophysiol       Date:  2018-08-04       Impact factor: 1.900

6.  Use of apixaban for an elderly patient with left atrial thrombus.

Authors:  Shintaro Dobashi; Tadashi Fujino; Takanori Ikeda
Journal:  BMJ Case Rep       Date:  2014-06-24

7.  Left atrial thrombus formation and resolution during dabigatran therapy: A Japanese Heart Rhythm Society report.

Authors:  Hideo Mitamura; Takayuki Nagai; Atsuyuki Watanabe; Seiji Takatsuki; Ken Okumura
Journal:  J Arrhythm       Date:  2015-03-04

Review 8.  Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.

Authors:  Fabio Marsico; Milena Cecere; Antonio Parente; Stefania Paolillo; Fabiana de Martino; Santo Dellegrottaglie; Bruno Trimarco; Pasquale Perrone Filardi
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

9.  Complete resolution of left atrial appendage thrombosis with oral dabigatran etexilate in a patient with Myotonic Dystrophy type 1 and atrial fibrillation.

Authors:  Anna Rago; Andrea Antonio Papa; Giulia Arena; Marco Mosella; Antonio Cassese; Alberto Palladino; Paolo Golino
Journal:  Acta Myol       Date:  2017-12-01

10.  Severe tricuspid bioprosthetic valve stenosis as an unusual cause of pulmonary embolism: a case report.

Authors:  Jwan A Naser; Arman Arghami; Mackram F Eleid; Sorin V Pislaru
Journal:  Eur Heart J Case Rep       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.